相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Comparison of non-invasive liver fibrosis biomarkers in HIV/HCV co-infected patients:: The fibrovic study -: ANRS HC02
Patrice Cacoub et al.
JOURNAL OF HEPATOLOGY (2008)
Natural history of chronic hepatitis B: Special emphasis on disease progression and prognostic factors
Giovanna Fattovich et al.
JOURNAL OF HEPATOLOGY (2008)
The clinical significance of persistently normal ALT in chronic hepatitis B infection
Michelle Lai et al.
JOURNAL OF HEPATOLOGY (2007)
Standardization of ROC curve areas for diagnostic evaluation of liver fibrosis markers based on prevalences of fibrosis stages
Thierry Poynard et al.
CLINICAL CHEMISTRY (2007)
Risk and predictors of mortality associated with chronic hepatitis B infection
Uchenna H. Iloeje et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2007)
The natural history and evaluation of standard treatment of chronic hepatitis B: A critical treatment criteria and end points
Ching-Lung Lai et al.
ANNALS OF INTERNAL MEDICINE (2007)
Chronic hepatitis B virus carriers in the immunotolerant phase of infection:: Histologic findings and outcome
Tony Andreani et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2007)
Sequential algorithms combining non-invasive markers and biopsy for the assessment of liver fibrosis in chronic hepatitis B
Giada Sebastiani et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2007)
Long-term outcome of chronic hepatitis B based on histological grade and stage
Byung Kyu Park et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2007)
A prospective analysis of the prognostic value of biomarkers (fibrotest) in patients with chronic hepatitis C
Yen Ngo et al.
CLINICAL CHEMISTRY (2006)
Non invasive fibrosis biomarkers reduce but not substitute the need for liver biopsy
Giada Sebastiani et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2006)
Intermethod calibration of alanine aminotransferase (ALT) and γ-glutamyltransferase (GGT) results:: application to Fibrotest® and Actitest® scores
G Férard et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2006)
Longitudinal assessment of histology surrogate markers (FibroTest-ActiTest) during lamivudine therapy in patients with chronic hepatitis B infection
T Poynard et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2005)
Biomarkers as a first-line estimate of injury in chronic liver diseases: Time for a moratorium on liver biopsy?
T Poynard et al.
GASTROENTEROLOGY (2005)
New science-based endpoints to accelerate oncology drug development
GJ Kelloff et al.
EUROPEAN JOURNAL OF CANCER (2005)
A reference material for traceability of aspartate aminotransferase (AST) results
G Ferard et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2005)
Prospective analysis of discordant results between biochemical markers and biopsy in patients with chronic hepatitis C
T Poynard et al.
CLINICAL CHEMISTRY (2004)
Intra-laboratory analytical variability of biochemical markers of fibrosis (Fibrotest) and activity (Actitest) and reference ranges in healthy blood donors (vol 42, pg 323, 2004)
F Imbert-Bismut et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2004)
Sampling variability of liver fibrosis in chronic hepatitis C
P Bedossa et al.
HEPATOLOGY (2003)
A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C
CT Wai et al.
HEPATOLOGY (2003)
Biochemical surrogate markers of liver fibrosis and activity in a randomized trial of peginterferon alfa-2b and ribavirin
T Poynard et al.
HEPATOLOGY (2003)
Prediction of liver histological lesions with biochemical markers in patients with chronic hepatitis B
RP Myers et al.
JOURNAL OF HEPATOLOGY (2003)
Biochemical markers of liver fibrosis in patients infected by hepatitis C virus: longitudinal validation in a randomized trial
T Poynard et al.
JOURNAL OF VIRAL HEPATITIS (2002)
分享论文
